Harnessing magic bullets to outsmart cancer

Infographic1 min read 19th Jul 2021

Share via email Share via LinkedIn

Share via email Share via LinkedIn

Sterling scientist in the lab using HPLCs

Blog6 min read

Deuteration in API development: Synthetic, analytical and engineering considerations Read more

Spotlight5 min read

Scientist Snapshot | Alex Tretyakov, Senior Technical Fellow (CR&D) Read more

A preview of the 'Understanding the impact of ultra-high potency APIs (UHPAPIs)' infographic

Infographic1 min read

Understanding the impact of ultra-high potency APIs Read more

Preview image of Sterling Biocatalysis whitepaper

Whitepaper8 min read

Biocatalysis: Leveraging natures catalysts in pharmaceutical development Read more

Solid state chemistry

Blog7 min read

Solid form: Why is it important to consider in API development? Read more

Preview image of Sterling's "the power of peptide therapeutics" whitepaper

Whitepaper13 min read

The power of peptide therapeutics: Advancements and methods in peptide drug development Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Email

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229